Holdings
Pivotal bioVenture Partners Investment Advisor LLC
As of Jun 30, 2026, Pivotal bioVenture Partners Investment Advisor LLC reported 12 positions worth US$287M. Largest: Vaxcyte, Inc., Arcutis Biotherapeutics, Inc. and Trevi Therapeutics, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Vaxcyte, Inc. | 1.43M | US$82.9M | +53,045 | Jun 30, 2026 |
| Arcutis Biotherapeutics, Inc. | 1.27M | US$33.2M | −90,609 | Jun 30, 2026 |
| Trevi Therapeutics, Inc. | 1.74M | US$32.5M | +189K | Jun 30, 2026 |
| Avalyn Pharma Inc. | 967K | US$31.8M | new | Jun 30, 2026 |
| Evommune, Inc. | 1.93M | US$25.6M | no change | Jun 30, 2026 |
| Maplight Therapeutics, Inc. | 611K | US$21.9M | −1 | Jun 30, 2026 |
| Bioage Labs, Inc. | 653K | US$16M | no change | Jun 30, 2026 |
| Immunome, Inc. | 733K | US$15.5M | no change | Jun 30, 2026 |
| Zenas Biopharma, Inc. | 491K | US$12.5M | −101K | Jun 30, 2026 |
| Avalo Therapeutics, Inc. | 434K | US$8.02M | +138K | Jun 30, 2026 |